RUN vs SPRB · P/E 6.0, rev $2.04B vs rev $4.9M
Sunrun Inc (RUN) versus Spruce Biosciences Inc (SPRB) — a side-by-side from cached financials, not a winner call.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Spruce Biosciences Inc (SPRB) is a biotechnology company listed on US.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Latest reported SPRB revenue for 2024-12-31 was $4.9M. Net income was -$53.0M. Revenue was down 51.3% from 2023-12-31 to 2024-12-31. SPRB currently screens at market cap $3.0M.
RUN currently screens at market cap $3.05B and trailing P/E 6.0. SPRB currently screens at market cap $3.0M.
Not investment advice. Open the RUN and SPRB stock pages for the full models.
Not investment advice.